Cargando…
COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study
BACKGROUND: In the midst of the COVID-19 pandemic, patients with cancer are regarded as a highly vulnerable population. Overall, those requiring hospital admission for treatment administration are potentially exposed to a higher risk of infection and worse outcome given the multiple in-hospital expo...
Autores principales: | Nichetti, Federico, Bini, Marta, Ambrosini, Margherita, Ottini, Arianna, Rametta, Alessandro, Leporati, Rita, Polastri, Daniela, Pircher, Chiara, Dotti, Katia, Ferrari, Laura, de Braud, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650074/ https://www.ncbi.nlm.nih.gov/pubmed/33158968 http://dx.doi.org/10.1136/esmoopen-2020-000883 |
Ejemplares similares
-
1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study
por: Nichetti, F., et al.
Publicado: (2020) -
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
por: Pietrantonio, Filippo, et al.
Publicado: (2020) -
CovInter: interaction data between coronavirus RNAs and host proteins
por: Amahong, Kuerbannisha, et al.
Publicado: (2022) -
Language and automata theory and applications: 14th international conference, LATA 2020, Milan, Italy, March 4-6, 2020, proceedings
por: Leporati, Alberto, et al.
Publicado: (2020) -
Twenty years of activity at the European Institute of Oncology, Milan, Italy
por: Cairns, Linda
Publicado: (2014)